RT-156

14th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 2000

Jan. 29 - Feb. 5, 2000
Marilleva, Trento, Italy

RT-156

Human atrial activation mapping: the role of structure and ultrastructure

Prapa Kanagaratnam, Vias Markides, Dominic W.Lamb, Richard J.Schilling, D. Wyn Davies, Anthony W.C. Chow, Pravina Patel, Nicholas S. Peters.
St Mary’s Hospital and Imperial College School of Medicine, London, UK

Role of ultrastructure: gap junctions, connexins and connective tissue

At the cellular level, membrane channel properties, gap-junctional coupling and local cellular architecture determine cardiac conduction1,2. We have used epicardial multi-electrode mapping combined with immunoconfocal quantification of gap-junctional proteins and interstitial connective tissue to understand the relationship between structure, ultrastructure and conduction properties at the tissue level. Gap junctions contain channels consisting of two hemi-channels, termed connexons2,3. Each connexon is constructed from six connexin proteins. Connexins are a multigene family of proteins, which have a high degree of molecular homology, but form gap junctions with different functional properties. In the human atrium, the predominant connexins are connexin43 (Cx43) and connexin40 (Cx40). Connexin45 (Cx45) has also been shown to be present at low levels. Gap junctions are considered to present rate-determining resistive discontinuities to propagation and the functional properties conferred by the relative levels of the connexins expressed are, therefore, thought to determine the conduction properties of myocardium. Extrapolating in-vitro cell pair or two-dimensional multicellular data to predict the role of ultrastructural determinants of conduction in the intact tissue is difficult because the properties of the tissue will be determined by not only the mode of intercellular communication and intracellular function, but also by the properties of the extracellular space and of the functional effects of the anatomical structures formed by tissue reorientation, folding and thickenening (such as at the crista terminalis, triangle of Koch).
In order to understand the role of gross structure and ultrastructure in conduction in the human right atrium, we have studied patients undergoing cardiac surgery. Epicardial mapping was performed on the intact right atrial free wall during sinus rhythm and pacing prior to commencing cardiopulmonary bypass, and a biopsy was excised from the mapped region. Careful positioning of the array with respect to the sulcus terminalis ensured a consistent position with the anterior 56 electrodes covering the trabeculated portion of the free wall. Electrograms were acquired on-line during sinus rhythm and (having inspected activation maps during sinus rhythm) pacing at 5 mA at a 500 ms interval from a site that closely simulated the direction of activation during sinus rhythm. Following mapping, an excision biopsy was taken from the mapped region of the trabeculated right atrial free wall before cardiopulmonary bypass was established. Three randomly selected consecutive sinus beats and three consecutive paced beats reproducing the direction and pattern of sinus propagation, were selected for off-line analysis. For each selected cycle, an activation time was assigned to each of the 56 electrodes overlying the trabeculated right atrium, at the maximum negative dV/dt deflection of the unipolar electrogram. The activation time of each electrode and those of the immediate neighbouring electrodes were used to calculate the local conduction velocities over the entire array by the method of triangulation.
The atrial myocardial biopsy was then prepared for immunolabeling of both Cx43 and Cx40. Connexin signal quantity was expressed per unit area of myocyte. The role of endomysial connective tissue (between individual myocytes) and total connective tissue (endomysial and perimysial-between muscle bundles) in determining conduction velocity was also investigated by quantifying endomysial connective tissue in subselected fields and represented as area of endomysial tissue per unit area of myocardial field.
We have found using these techniques that although there is no apparent relationship between conduction velocity and the quantity of Cx43 signal or of total connexin signal (Cx40+Cx43), an increase in the quantity of Cx40 signal was associated with a reduction in conduction velocity during sinus rhythm (p=0.036). There was a stronger correlation between the relative quantities of immunolabel (Cx40/Cx40+Cx43) and conduction velocity during sinus rhythm (p<0.005), such that as the proportion of Cx40 immunolabel increased the conduction velocity decreased4. Conduction velocity during pacing at 500 ms intervals did not correlate with the quantity of Cx40, Cx43, total connexin signal or the relative immunofluorescence of the two connexins. However, the relative signal quantity of immunolabeled Cx40 to total connexin (Cx40/Cx40+Cx43) correlated with the change in conduction velocity during pacing (mean paced conduction velocity – mean sinus conduction velocity) such that a lower proportion of Cx40 was associated with a decrease in conduction velocity at a shorter cycle length (p<0.02). The quantities of Cx40, Cx43 and total connexin signals did not correlate with the changes seen during pacing. Neither the mean total connective tissue autofluorescence (endomysial+perimysial connective tissue) nor endomysial autofluorescence alone correlated with sinus conduction velocity, paced conduction velocity or change in conduction velocity on pacing.
The results of the study, therefore, indicate that the relationship between Cx40 immunofluorescence and conduction velocity is not simple. The findings suggest either that Cx40 and Cx43 form heteromeric connexons in such a manner that an increasing proportion of Cx40 reduces coupling or that Cx40 somehow inhibits the formation of functional homomeric Cx43 connexons thereby reducing coupling. In addition, at the whole tissue level, it appears that the connective tissue content has little impact on conduction properties.

 

backward

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-2000 by CARDIOnet. All rights reserved.